Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Morris Gabriel S, holds the title of CFO, President at Immix Biopharma, Inc..
On 2026-11-18, the insider transacted 1,418 shares.The shares were transacted at a weighted average price of $7.06 per share, resulting in a total market-relevant value of $10K.
Morris Gabriel S (CFO, President) bought $10K of $IMMX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.